Regentis Biomaterials Ltd. (RGNT)
NYSEAMERICAN: RGNT · Real-Time Price · USD
1.190
+0.020 (1.71%)
Nov 6, 2026, 4:00 PM EST - Market closed
Regentis Biomaterials Market Cap
Regentis Biomaterials has a market cap or net worth of $8.36 million as of November 6, 2026. It is the 42,389th most valuable company in the world and the 5,669th biggest in the United States.
Market Cap
8.36M
Enterprise Value
-564.53K
1-Year Change
n/a
Global Rank
Country Rank
#5,669 United States
Category
ChartMarket Cap Chart
Since the IPO on December 4, 2025, Regentis Biomaterials's market cap has decreased from $39.44M to $8.36M, a decrease of -78.80%. That is a compound annual growth rate of -81.37%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2026 | 8.36M | -76.06% |
| Dec 31, 2025 | 34.91M | -11.48% |
| Dec 4, 2025 | 39.44M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Daxor | 49.33M |
| Davion Healthcare | 39.75M |
| Harvard Bioscience | 38.06M |
| Nephros | 30.30M |
| Milestone Scientific | 26.80M |
| Retractable Technologies | 16.93M |
| Bionano Genomics | 13.54M |
| Cuprina Holdings (Cayman) Limited | 12.61M |